2

The information and data presented here was prepared for investors and potential investors. It includes forward-looking information on investigational products in development that are not available for sale in the United States. These include early-stage development products for which the performance characteristics have not yet been established.

Investor & Analyst Day key takeaways

Cologuard® execution: Offering significant benefits to patients

and providers through advanced screening; ramp accelerating

Management strength: Experienced team and track record of execution

Impactful pipeline: Leveraging first-of-its-kind commercial product

to increase shareholder value

Industry leader: Product development, regulatory reviews

and commercialization

Exact Sciences is committed to helping win the war on cancer through

early detection

OUR VISION

5